• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病遗传缺失:非编码遗传变异的作用日益凸显。

Missing heritability in Parkinson's disease: the emerging role of non-coding genetic variation.

机构信息

LCSB, University of Luxembourg, Belvaux, Luxembourg.

Department of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.

出版信息

J Neural Transm (Vienna). 2020 May;127(5):729-748. doi: 10.1007/s00702-020-02184-0. Epub 2020 Apr 4.

DOI:10.1007/s00702-020-02184-0
PMID:32248367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7242266/
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic and environmental factors. For the stratification of PD patients and the development of advanced clinical trials, including causative treatments, a better understanding of the underlying genetic architecture of PD is required. Despite substantial efforts, genome-wide association studies have not been able to explain most of the observed heritability. The majority of PD-associated genetic variants are located in non-coding regions of the genome. A systematic assessment of their functional role is hampered by our incomplete understanding of genotype-phenotype correlations, for example through differential regulation of gene expression. Here, the recent progress and remaining challenges for the elucidation of the role of non-coding genetic variants is reviewed with a focus on PD as a complex disease with multifactorial origins. The function of gene regulatory elements and the impact of non-coding variants on them, and the means to map these elements on a genome-wide level, will be delineated. Moreover, examples of how the integration of functional genomic annotations can serve to identify disease-associated pathways and to prioritize disease- and cell type-specific regulatory variants will be given. Finally, strategies for functional validation and considerations for suitable model systems are outlined. Together this emphasizes the contribution of rare and common genetic variants to the complex pathogenesis of PD and points to remaining challenges for the dissection of genetic complexity that may allow for better stratification, improved diagnostics and more targeted treatments for PD in the future.

摘要

帕金森病(PD)是一种神经退行性疾病,由遗传和环境因素的复杂相互作用引起。为了对 PD 患者进行分层,以及开展包括病因治疗在内的先进临床试验,需要更好地了解 PD 的潜在遗传结构。尽管付出了巨大努力,但全基因组关联研究仍未能解释大部分观察到的遗传率。大多数与 PD 相关的遗传变异位于基因组的非编码区域。由于我们对基因型-表型相关性的理解不完整,例如通过基因表达的差异调节,对其功能作用进行系统评估受到阻碍。本文重点介绍 PD 是一种具有多因素起源的复杂疾病,综述了非编码遗传变异作用阐明的最新进展和仍然存在的挑战。将阐述基因调控元件的功能以及非编码变异对它们的影响,以及在全基因组水平上对这些元件进行映射的方法。此外,还将举例说明如何整合功能基因组注释来识别与疾病相关的途径,并优先考虑与疾病和细胞类型特异性相关的调控变异。最后,概述了功能验证的策略和合适的模型系统的考虑因素。综上所述,这强调了罕见和常见遗传变异对 PD 复杂发病机制的贡献,并指出了在遗传复杂性剖析方面仍存在的挑战,这可能有助于未来更好地对 PD 进行分层、提高诊断水平并进行更有针对性的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/53aab8068aaf/702_2020_2184_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/5e5c871ac785/702_2020_2184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/c7879dcd3c39/702_2020_2184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/b6e67e669a5c/702_2020_2184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/53aab8068aaf/702_2020_2184_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/5e5c871ac785/702_2020_2184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/c7879dcd3c39/702_2020_2184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/b6e67e669a5c/702_2020_2184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3345/7242266/53aab8068aaf/702_2020_2184_Fig4_HTML.jpg

相似文献

1
Missing heritability in Parkinson's disease: the emerging role of non-coding genetic variation.帕金森病遗传缺失:非编码遗传变异的作用日益凸显。
J Neural Transm (Vienna). 2020 May;127(5):729-748. doi: 10.1007/s00702-020-02184-0. Epub 2020 Apr 4.
2
GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.GCH1 变异与帕金森病的风险和发病年龄提前有关:一项两队列病例对照研究。
Transl Neurodegener. 2020 Aug 4;9(1):31. doi: 10.1186/s40035-020-00212-3.
3
Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India.全基因组多基因风险评分可预测印度单基因未确诊早发性帕金森病患者中的大量高危个体。
Adv Biol (Weinh). 2022 Nov;6(11):e2101326. doi: 10.1002/adbi.202101326. Epub 2022 Jul 10.
4
The Role of Structural Variants in the Genetic Architecture of Parkinson's Disease.结构变异在帕金森病遗传结构中的作用。
Int J Mol Sci. 2024 Apr 27;25(9):4801. doi: 10.3390/ijms25094801.
5
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.内吞膜运输途径在帕金森病的风险中起着重要作用。
Mov Disord. 2019 Apr;34(4):460-468. doi: 10.1002/mds.27614. Epub 2019 Jan 24.
6
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.在非洲和非洲混合人群中与帕金森病相关的遗传风险基因座和因果关系的鉴定:一项全基因组关联研究。
Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23.
7
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.帕金森病多基因风险评分的有效性和预后价值。
Genes (Basel). 2021 Nov 23;12(12):1859. doi: 10.3390/genes12121859.
8
Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.线粒体途径中的罕见遗传变异会影响帕金森病的风险。
Mov Disord. 2018 Oct;33(10):1591-1600. doi: 10.1002/mds.64. Epub 2018 Sep 5.
9
Establishing the role of rare coding variants in known Parkinson's disease risk loci.确定罕见编码变异在已知帕金森病风险基因座中的作用。
Neurobiol Aging. 2017 Nov;59:220.e11-220.e18. doi: 10.1016/j.neurobiolaging.2017.07.009. Epub 2017 Aug 2.
10
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.全基因组关联研究揭示非洲及非裔混血人群中与帕金森病相关的新病因学见解。
medRxiv. 2023 May 7:2023.05.05.23289529. doi: 10.1101/2023.05.05.23289529.

引用本文的文献

1
A report of the Iranian Parkinson's disease registry.一份关于伊朗帕金森病登记处的报告。
NPJ Parkinsons Dis. 2025 Aug 21;11(1):251. doi: 10.1038/s41531-025-01108-7.
2
Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson's disease.GAK基因中的低频遗传变异增强高尔基体功能并预防帕金森病。
medRxiv. 2025 Aug 15:2025.08.13.25333123. doi: 10.1101/2025.08.13.25333123.
3
Genetic variants associated with idiopathic Parkinson's disease in Latin America: A systematic review.拉丁美洲与特发性帕金森病相关的基因变异:一项系统综述。

本文引用的文献

1
Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk.帕金森病中单核苷酸变异缺失过多导致遗传风险增加。
J Med Genet. 2020 Sep;57(9):617-623. doi: 10.1136/jmedgenet-2019-106316. Epub 2020 Feb 13.
2
Towards a comprehensive catalogue of validated and target-linked human enhancers.迈向一个全面的已验证和与靶标相关的人类增强子目录。
Nat Rev Genet. 2020 May;21(5):292-310. doi: 10.1038/s41576-019-0209-0. Epub 2020 Jan 27.
3
LRRK2 in Parkinson disease: challenges of clinical trials.LRRK2 在帕金森病中的作用:临床试验面临的挑战。
Neurogenetics. 2025 Apr 3;26(1):43. doi: 10.1007/s10048-025-00817-8.
4
Genetic resonance: dissecting the heritability and genetic correlations of human hearing acuity.基因共振:剖析人类听力敏锐度的遗传力和基因相关性。
G3 (Bethesda). 2025 Feb 5;15(2). doi: 10.1093/g3journal/jkae292.
5
Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing.帕金森病患者脑组织的转录组学研究:批量和单细胞 RNA 测序的比较。
Mol Neurobiol. 2024 Nov;61(11):8996-9015. doi: 10.1007/s12035-024-04124-5. Epub 2024 Apr 5.
6
Defining Parkinson's Disease: Past and Future.定义帕金森病:过去与未来。
J Parkinsons Dis. 2024;14(s2):S257-S271. doi: 10.3233/JPD-230411.
7
Luxembourg Parkinson's study -comprehensive baseline analysis of Parkinson's disease and atypical parkinsonism.卢森堡帕金森病研究——帕金森病和非典型帕金森综合征的综合基线分析
Front Neurol. 2023 Dec 19;14:1330321. doi: 10.3389/fneur.2023.1330321. eCollection 2023.
8
SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson's disease.细胞色素P450基因中的单核苷酸多态性决定了具有帕金森病遗传易感性个体的命运。
Front Pharmacol. 2023 Aug 4;14:1244516. doi: 10.3389/fphar.2023.1244516. eCollection 2023.
9
Shared molecular genetic factors influence subcortical brain morphometry and Parkinson's disease risk.共享的分子遗传因素影响皮质下脑形态测量和帕金森病风险。
NPJ Parkinsons Dis. 2023 May 10;9(1):73. doi: 10.1038/s41531-023-00515-y.
10
Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson's disease genes.全转录组关联研究与神经元功能障碍测定相结合为帕金森病基因提供了功能基因组学证据。
Hum Mol Genet. 2023 Jan 27;32(4):685-695. doi: 10.1093/hmg/ddac230.
Nat Rev Neurol. 2020 Feb;16(2):97-107. doi: 10.1038/s41582-019-0301-2. Epub 2020 Jan 24.
4
Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score.LRRK2 p.G2019S 携带者帕金森病的外显率受多基因风险评分的影响。
Mov Disord. 2020 May;35(5):774-780. doi: 10.1002/mds.27974. Epub 2020 Jan 20.
5
The Role of Rare Coding Variants in Parkinson's Disease GWAS Loci.罕见编码变异在帕金森病全基因组关联研究位点中的作用
Front Neurol. 2019 Dec 13;10:1284. doi: 10.3389/fneur.2019.01284. eCollection 2019.
6
Mechanisms of tissue and cell-type specificity in heritable traits and diseases.遗传性状和疾病的组织和细胞类型特异性的机制。
Nat Rev Genet. 2020 Mar;21(3):137-150. doi: 10.1038/s41576-019-0200-9. Epub 2020 Jan 8.
7
Common genetic variants associated with Parkinson's disease display widespread signature of epigenetic plasticity.常见的帕金森病相关遗传变异显示出广泛的表观遗传可塑性特征。
Sci Rep. 2019 Dec 5;9(1):18464. doi: 10.1038/s41598-019-54865-w.
8
The landscape of multiscale transcriptomic networks and key regulators in Parkinson's disease.帕金森病多尺度转录组网络和关键调控因子的研究进展。
Nat Commun. 2019 Nov 20;10(1):5234. doi: 10.1038/s41467-019-13144-y.
9
Ranking of non-coding pathogenic variants and putative essential regions of the human genome.人类基因组中非编码致病性变异体和推定必需区域的排名。
Nat Commun. 2019 Nov 20;10(1):5241. doi: 10.1038/s41467-019-13212-3.
10
Brain cell type-specific enhancer-promoter interactome maps and diseaserisk association.脑细胞类型特异性增强子-启动子互作图谱与疾病风险关联。
Science. 2019 Nov 29;366(6469):1134-1139. doi: 10.1126/science.aay0793. Epub 2019 Nov 14.